Dr. Michelle Stoltzman, MD

Dr. Stoltzman practices at Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center.

Dr. Stoltzman's NPI, 1194164954, was assigned on June 14, 2013. Dr. Stoltzman graduated from Saba University School of Medicine in 2013. Dr. Stoltzman holds California license A171235.

Dr. Stoltzman's primary practice is Eisenhower Health, at 39-000 Bob Hope Drive, Rancho Mirage, CA 92270 in Riverside County. The practice phone is (760) 340-3911. Dr. Stoltzman also practices at Eisenhower Medical Center, 39000 Bob Hope Dr, Rancho Mirage, CA 92270.

Dr. Stoltzman's primary practice is Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center. Dr. Stoltzman is also affiliated with Desert Regional Medical Center. The medical group on file is Eisenhower Health. Dmand AI also links Dr. Stoltzman to 1 more breast imaging center, 1 clinical lab and 1 dialysis center, each named with a free account. Dr. Stoltzman's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stoltzman practices, 5 sites in all. Vendor and product names are available with a free account.

Obstetrics and gynecology is Dr. Stoltzman's primary specialty in the NPI Registry, under taxonomy code 207V00000X. Dr. Stoltzman is board certified in obstetrics & gynecology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Stoltzman's licenses on file in 4 states: California, Florida, Georgia and Connecticut.

Dmand AI lists bladder disease, menopause, ovarian cyst, pelvic prolapse, UTI and vaginal infection among the conditions Dr. Stoltzman treats.

CMS data shows 1,270 Medicare services from Dr. Stoltzman across 11 procedure codes in 2024, for 478 Medicare patients. Medicare paid $66,713 for them.

CMS counts 478 Medicare patients who saw Dr. Stoltzman in 2024. The largest group is 65 to 74, with 241 patients. 75% of them have high cholesterol, and 62% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.86, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stoltzman's median patient age at 70, with 95% women.

In 2024, Dr. Stoltzman wrote 952 Medicare Part D claims for 297 patients. 84% of them were for generic drugs. CMS names the drug for 849 of them, across 16 drugs with 11 or more claims each, at $56,527 in total drug cost. In 2023, CMS named 572 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Stoltzman for performance year 2024, reported as part of a group. Dr. Stoltzman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stoltzman as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Stoltzman. Dr. Stoltzman's most frequent co-authors are Jamie Hsien-Chin Chao, MD, Marsha Kathleen Guess, MD, MS and Devin Tatcher Miller, MD.

CMS Open Payments shows 25 general payments to Dr. Stoltzman from 13 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 97% of the total. Hologic Inc paid the most, $378.

Dr. Stoltzman graduated from Saba University School of Medicine in 2013.

Dr. Stoltzman is in network with 14 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.